241 related articles for article (PubMed ID: 23677609)
1. A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy.
Dong B; Moore AR; Dai J; Roberts S; Chu K; Kapranov P; Moss B; Xiao W
Nucleic Acids Res; 2013 Jul; 41(13):6609-17. PubMed ID: 23677609
[TBL] [Abstract][Full Text] [Related]
2. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
Xiao X; Li J; Samulski RJ
J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
[TBL] [Abstract][Full Text] [Related]
3. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
5. Replication competent helper functions for recombinant AAV vector generation.
Cao L; During M; Xiao W
Gene Ther; 2002 Sep; 9(18):1199-206. PubMed ID: 12215886
[TBL] [Abstract][Full Text] [Related]
6. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
Cao L; Liu Y; During MJ; Xiao W
J Virol; 2000 Dec; 74(24):11456-63. PubMed ID: 11090141
[TBL] [Abstract][Full Text] [Related]
7. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
Whiteway A; Deru W; Prentice HG; Anderson R
J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
9. Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system.
Feudner E; de Alwis M; Thrasher AJ; Ali RR; Fauser S
J Virol Methods; 2001 Aug; 96(2):97-105. PubMed ID: 11445141
[TBL] [Abstract][Full Text] [Related]
10. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
[TBL] [Abstract][Full Text] [Related]
11. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
12. Herpes Simplex Virus 1 Coinfection Modifies Adeno-associated Virus Genome End Recombination.
Meier AF; Tobler K; Michaelsen K; Vogt B; Henckaerts E; Fraefel C
J Virol; 2021 Jun; 95(13):e0048621. PubMed ID: 33853961
[TBL] [Abstract][Full Text] [Related]
13. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.
Wang XS; Khuntirat B; Qing K; Ponnazhagan S; Kube DM; Zhou S; Dwarki VJ; Srivastava A
J Virol; 1998 Jul; 72(7):5472-80. PubMed ID: 9621003
[TBL] [Abstract][Full Text] [Related]
14. Construction of an rAAV Producer Cell Line through Synthetic Biology.
Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
[TBL] [Abstract][Full Text] [Related]
15. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
Li C; Samulski RJ
Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
[TBL] [Abstract][Full Text] [Related]
16. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
17. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
18. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
19. HPV-16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2 and wt AAV2 production.
Cao M; Zhu H; Bandyopadhyay S; You H; Hermonat PL
Gene Ther; 2012 Apr; 19(4):418-24. PubMed ID: 21850053
[TBL] [Abstract][Full Text] [Related]
20. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production.
Allen JM; Debelak DJ; Reynolds TC; Miller AD
J Virol; 1997 Sep; 71(9):6816-22. PubMed ID: 9261406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
